The involvement of XPC protein in the cisplatin DNA damaging treatment-mediated cellular response.
about
Involvement of nucleotide excision and mismatch repair mechanisms in double strand break repairBiochemical and structural domain analysis of xeroderma pigmentosum complementation group C protein.Regulators of global genome repair do not respond to DNA damaging therapy but correlate with survival in melanoma.Vasohibin 2 decreases the cisplatin sensitivity of hepatocarcinoma cell line by downregulating p53.Global transcriptional responses to cisplatin in Dictyostelium discoideum identify potential drug targetsMiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway.DNA Repair Gene Polymorphism and the Risk of Mitral Chordae Tendineae Rupture.Xeroderma pigmentosum complementation group C genotypes/diplotypes play no independent or interaction role with polycyclic aromatic hydrocarbons-DNA adducts for breast cancer risk.BRAF(V600E) efficient transformation and induction of microsatellite instability versus KRAS(G12V) induction of senescence markers in human colon cancer cells.Coordination of centrosome homeostasis and DNA repair is intact in MCF-7 and disrupted in MDA-MB 231 breast cancer cellsSingle nucleotide polymorphisms of nucleotide excision repair pathway are significantly associated with outcomes of platinum-based chemotherapy in lung cancer.Clinicopathological significance and prognostic value of Xeroderma pigmentosum complementary group C (XPC) expression in sporadic breast cancer patients.Sequential decitabine and carboplatin treatment increases the DNA repair protein XPC, increases apoptosis and decreases proliferation in melanoma.Nucleotide Excision Repair Factor XPC Ameliorates Prognosis by Increasing the Susceptibility of Human Colorectal Cancer to Chemotherapy and Ionizing Radiation
P2860
Q24649491-9DCF1777-FF06-4C68-A3DD-9A15FCE639FAQ33265872-E32C5175-7306-41C9-86AA-CC155E997B19Q34935043-3D44407B-746C-4B3B-A524-3B520E60B4FDQ35111116-AB146B34-3617-4D4D-A648-8A6F52105C58Q36024142-921C3DFC-405C-405D-BE28-CB37DDB9A31EQ36246037-F13EFCA1-07DF-45A2-BC8D-504D0E75EC1FQ36269884-C5DC60F6-994A-4D41-9038-7E632FB7B3A7Q36666614-27AB1F92-F6D6-411A-BC62-DB896CCD0365Q37399265-B3DD3CCC-23EC-4705-87CC-15BB2F787863Q39715273-128733E5-B742-4231-BC69-F325456E09D2Q41718006-939D4C5A-95E6-454C-9FD6-D9F9D0B632FBQ44576576-B367D714-B3C0-487A-BBB9-D39982B3E7F8Q48158660-4B33E04A-7F36-4D67-8835-4439AEB6A486Q57071789-0EB17FA9-BD82-4E34-9848-A2B5E923F117
P2860
The involvement of XPC protein in the cisplatin DNA damaging treatment-mediated cellular response.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
The involvement of XPC protein ...... nt-mediated cellular response.
@en
type
label
The involvement of XPC protein ...... nt-mediated cellular response.
@en
prefLabel
The involvement of XPC protein ...... nt-mediated cellular response.
@en
P2093
P2860
P356
P1433
P1476
The involvement of XPC protein ...... ent-mediated cellular response
@en
P2093
Lynn Chuang
Xiao Xin S Xu
P2860
P2888
P304
P356
10.1038/SJ.CR.7290375
P577
2004-08-01T00:00:00Z